DexCom, Inc.(DXCM): For the most recent quarter end, DexCom, Inc. reported Annual Earnings of $-0.22. Based on the filings, last years Annual Earnings was, $-0.26. For the most recent quarter end, DXCM reported a surprise Earnings per Share of -57.14% . The consensus estimate for current quarter is $-0.09 and for the current fiscal year, the estimate is $-0.78. For the Next fiscal year, the estimate is $-0.28 based on the consensus.
DexCom, Inc. has received $-0.09 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 13 Financial Advisor in the Stock Trading Firms. Among 13 Analysts, Bottom line EPS Estimate for the current quarter is $-0.15 while the top line estimate is $0.08 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at -526.92%. DexCom, Inc. results fell short with a surprise EPS of -57.14% or $-0.08. The Actual EPS was $-0.22 compared to the Estimated EPS of $-0.14 during its most recent quarterly earnings.
DexCom Last issued its quarterly earnings results on Nov 1, 2016. The company reported $-0.07 EPS for the quarter, beating the analyst consensus estimate by $ 0.06. Analyst had a consensus of $-0.13. The company had revenue of $148.60 million for the quarter, compared to analysts expectations of $146.63 million. The companys revenue was up 41.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.07 EPS.
Company has reported several Insider transactions to the SEC, on Feb 14, 2017, Andrew K Balo (EVP, Clinical and Regulatory) sold 3,200 shares at 79.30 per share price.On Feb 13, 2017, John Lister (General Manager, EMEA) sold 3,000 shares at 79.74 per share price.On Feb 13, 2017, Jorge A Valdes (CTO) sold 7,000 shares at 79.76 per share price.
DexCom, Inc. (NASDAQ:DXCM) witnessed a decline in the market cap on Wednesday as its shares dropped 1.64% or 1.31 points. After the session commenced at $79.88, the stock reached the higher end at $79.89 while it hit a low of $78.02. With the volume soaring to 853,838 shares, the last trade was called at $78.59. The company has a 52-week high of $96.38. The company has a market cap of $6,643 million and there are 84,524,171 shares in outstanding. The 52-week low of the share price is $56.52.
Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.